← Back to headlines
Oppenheimer Maintains 'Outperform Rating' on Pharmaceuticals, Inc. (IONS)
Oppenheimer has reiterated its 'Outperform Rating' for Pharmaceuticals, Inc. (IONS), indicating a positive outlook on the company's stock performance.
13 May, 17:53 — 13 May, 17:53
Sources
Showing 1 of 1 sources
